Professional Summary
Professional Overview
Susan Smith is a seasoned pharmaceutical executive with over 20 years of experience in the oncology and hematology sectors. As the Senior Director of Scientific Alliances at Novartis Oncology, she is responsible for leading strategic collaborations and partnerships that advance the company's pipeline of innovative cancer treatments. With a strong background in clinical pharmacy and a deep understanding of the evolving oncology landscape, Susan brings a unique blend of scientific expertise and business acumen to her role.
Experience Summary
Current Role
In her current position as Senior Director, Scientific Alliances IM-US at Novartis Oncology, Susan is responsible for identifying, negotiating, and managing strategic partnerships with academic institutions, research organizations, and other pharmaceutical companies. She plays a pivotal role in driving the company's scientific and clinical collaborations, ensuring that Novartis remains at the forefront of oncology research and development. Under her leadership, the scientific alliance team has secured several high-profile partnerships, contributing to the advancement of Novartis' oncology pipeline and enhancing the company's position as a leader in the field.
Career Progression
Prior to her current role, Susan served as an Oncology Medical Science Liaison at Novartis, where she leveraged her extensive clinical expertise to provide scientific and medical support to healthcare professionals. Before joining Novartis, she held the position of Hematology/Oncology Pharmacist at Children's Healthcare of Atlanta, where she played a crucial role in the management and optimization of patient care for oncology and hematology patients. Earlier in her career, Susan gained valuable experience as a Pharmacy Manager at Walmart Pharmacy and as a Consultant Pharmacist at Sunscript Pharmacy.
Academic Background
Susan holds a Doctor of Pharmacy (PharmD) degree from the University of Georgia College of Pharmacy, where she graduated with distinction. Her specialized training in oncology and hematology has been instrumental in shaping her career trajectory and enabling her to make significant contributions to the pharmaceutical industry.
Areas of Expertise
- Oncology and hematology drug development
- Strategic alliance management and partnership building
- Medical and scientific communications
- Clinical pharmacy practice and patient care
- Cross-functional collaboration and project management
Professional Impact
Throughout her career, Susan has demonstrated a strong commitment to advancing the field of oncology. In her current role, she has been instrumental in securing several high-impact partnerships that have accelerated the development of Novartis' oncology pipeline. Her expertise in translating complex scientific data into actionable insights has been invaluable in driving the success of these collaborations. Susan's contributions have been recognized by her peers, and she is frequently invited to speak at industry conferences and events, sharing her insights and best practices with the broader pharmaceutical community.
Conclusion
With her extensive experience, scientific expertise, and proven track record of successful strategic alliances, Susan Smith is a valuable asset to Novartis Oncology. Her ability to navigate the evolving oncology landscape and forge meaningful partnerships positions her as a respected leader in the industry. As she continues to drive innovation and advance the company's oncology pipeline, Susan remains committed to making a lasting impact on the lives of cancer patients worldwide.
